Zhigang Nian
National Key Laboratory Of Immune Response And Immunotherapy
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inhibition of the lipocalin-2-phosphatidylserine axis restores natural killer cell immune surveillance.
Journal: Cell reports. Medicine
Published: February 03, 2026
p53: An Immune Ecosystem Manipulator.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2025
Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion.
Journal: Cell reports
Published: September 29, 2024
The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia.
Journal: Blood transfusion = Trasfusione del sangue
Published: March 23, 2024
Reconstituted CD74+ NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation.
Journal: Journal of autoimmunity
Published: February 02, 2024
Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation.
Journal: Immunity
Published: September 25, 2023
Human-Induced CD49a+ NK Cells Promote Fetal Growth.
Journal: Frontiers in immunology
Published: December 07, 2021
Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 03, 2021
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling.
Journal: EBioMedicine
Published: March 27, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026